Visit https://www.peervoice.com/XBY860 to view the entire programme with slides. After completing “A Look at Emerging SMA Outcomes: Highlights of EAN 2020”, participants will be able to: Describe the pathogenesis of SMA in terms of potential therapeutic targets; Review current progress in terms of diagnosis and management; and Analyse clinical evidence for novel therapeutic targets in terms of outcomes and safety.